Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2025-12-26 @ 10:59 AM
Study NCT ID:
NCT06353906
Status:
RECRUITING
Last Update Posted:
2025-12-08
First Post:
2024-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-15
First Submit QC Date:
None
Study First Post Date:
2024-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED